Cleared Traditional

Motive™ Electrode (K230533) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K230533 · Cymedica Orthopedics, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
23d
Days
Class 2
Risk

K230533 is an FDA 510(k) clearance for the Motive™ Electrode. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Cymedica Orthopedics, Inc. (Tempe, US). The FDA issued a Cleared decision on March 22, 2023 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cymedica Orthopedics, Inc. devices

Submission Details

510(k) Number K230533 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 2023
Decision Date March 22, 2023
Days to Decision 23 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
125d faster than avg
Panel avg: 148d · This submission: 23d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 97
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K230533.
Ceribell Instant EEG Headband
K232052 · Ceribell, Inc. · Aug 2023
Starly pad
K221589 · Shenzhen Xingyuanli Technology Co., Ltd. · Mar 2023
Ceribell Instant EEG Headcap
K223086 · Ceribell, Inc. · Mar 2023
DeltaScan Patch
K222671 · Prolira B.V. · Feb 2023
Garment Electrodes
K222863 · Tone-A-Matic International, Inc. · Feb 2023
Disposable Non-invasive EEG Sensor
K220448 · Shenzhen Med-Link Electronics Tech Co., Ltd. · Jan 2023